J T Chambers

No ORCID on file · 4 papers in corpus
other 1992
Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma
Gynecologic Oncology ·doi:10.1016/0090-8258(92)90130-b

One hundred eight cases of uterine papillary serous carcinoma (UPSC) were analyzed to characterize its histologic features and biologic behavior. Special situations that could conceivably modify the behavior and therapeutic approaches were …

review 1989
Borderline ovarian tumors: a review of treatment
The Yale journal of biology and medicine

Borderline ovarian tumors have an excellent prognosis. In stage I disease, no therapy in addition to surgery is needed, and conservation of ovarian tissue for future childbearing may be appropriate. In advanced stages, the use of adjuvant t…

article 1989
Circulating levels of CSF-1 (M-CSF) a lymphohematopoietic cytokine may be a useful marker of disease status in patients with malignant ovarian neoplasms
International journal of radiation oncology, biology, physics ·doi:10.1016/0360-3016(89)90383-0

We have previously reported our observations of epithelial tumor cell expression of transcripts and protein antigens of CSF-1 and transcripts of a protein closely related--if not identical--to the CSF-1 receptor in ovarian and endometrial n…

case-report 1989
Development of leukemia after doxorubicin and cisplatin treatment for ovarian cancer
Cancer ·doi:10.1002/1097-0142(19891215)64:12<2459::aid-cncr2820641210>3.0.co;2-t

Alkylating agents have been the major group of chemotherapeutic agents associated with an increased incidence of secondary leukemias. In ovarian cancer alkylating agents have resulted in a lesser, although still increased, risk of secondary…